Spruce Biosciences, Inc. (SPRB)

Spruce Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	60.06	96.34	24.49	42.75	157.15	3.92
Short-Term Investments	-	-	54.59	46.22	-	-
Cash & Short-Term Investments	60.06	96.34	79.08	88.97	157.15	3.92
Cash Growth	-44.41%	21.83%	-11.12%	-43.39%	3904.84%	-4.57%
Prepaid Expenses	2.66	3.88	3.32	2.53	2.97	0.22
Restricted Cash	-	-	0.22	-	-	-
Other Current Assets	0.86	1.97	1	0.4	0.28	0.51
Total Current Assets	63.57	102.18	83.61	91.9	160.4	4.65
Property, Plant & Equipment	1	1.18	1.4	1.48	1.87	-
Long-Term Investments	-	-	-	32.46	-	-
Other Long-Term Assets	0.53	0.58	0.64	0.65	0.62	0.04
Total Assets	65.1	103.95	85.65	126.49	162.88	4.69
Accounts Payable	1.8	3.33	1.43	2.82	3.63	1.88
Accrued Expenses	7.47	14.35	9.26	5.69	3.33	1.17
Current Portion of Long-Term Debt	1.62	1.62	1.62	-	2.55	1.25
Current Portion of Leases	0.28	0.25	0.14	0.36	0.25	-
Current Unearned Revenue	0.7	4.91	-	-	-	-
Total Current Liabilities	11.86	24.47	12.45	8.87	9.76	4.3
Long-Term Debt	0.52	1.72	3.29	4.88	1.92	3.19
Long-Term Leases	0.81	1.02	1.26	1.29	1.65	-
Other Long-Term Liabilities	0.27	0.24	0.16	0.07	0.12	0.02
Total Liabilities	13.46	27.44	17.16	15.12	13.46	7.52
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	278.34	273.74	218.35	214.69	210.27	0.66
Retained Earnings	-226.71	-197.23	-149.31	-103.13	-60.84	-31.3
Comprehensive Income & Other	-	-	-0.56	-0.18	-	-
Total Common Equity	51.64	76.51	68.49	111.37	149.43	-30.64
Shareholders' Equity	51.64	76.51	68.49	111.37	149.43	-2.82
Total Liabilities & Equity	65.1	103.95	85.65	126.49	162.88	4.69
Total Debt	3.23	4.61	6.32	6.53	6.38	4.45
Net Cash (Debt)	56.83	91.73	72.76	82.44	150.77	-0.52
Net Cash Growth	-44.81%	26.07%	-11.74%	-45.32%	-	-
Net Cash Per Share	1.38	2.38	3.09	3.53	25.17	-0.68
Filing Date Shares Outstanding	41.3	41.15	39.75	23.49	23.3	0.77
Total Common Shares Outstanding	41.3	41.03	23.6	23.49	23.26	0.76
Working Capital	51.72	77.72	71.16	83.02	150.63	0.35
Book Value Per Share	1.25	1.86	2.90	4.74	6.42	-40.08
Tangible Book Value	51.64	76.51	68.49	111.37	149.43	-30.64
Tangible Book Value Per Share	1.25	1.86	2.90	4.74	6.42	-40.08
Machinery	-	-	-	-	0.06	-
Leasehold Improvements	-	-	-	-	0.01	-

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q